Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents. 2021

Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
Department of Chemistry, Zhejiang University, Hangzhou, P. R. China.

Colorectal cancer (CRC) is a common malignant tumour of human digestive tract. The high mortality rate of CRC is closely related to the limitations of existing treatments. Thus, there is an urgent need to search for new anti-CRC agents. In this work, twenty novel coumarin-dithiocarbamate derivatives (IDs) were designed, synthesized and evaluated in vitro. The results suggest that the most active compound ID-11 effectively inhibited the proliferation of CRC cell lines while shown little impact on normal colon epithelial cells. Mechanism studies revealed that ID-11 displayed bromodomain-containing protein 4 inhibitory activity, and induced G2/M phase arrest, apoptosis as well as decreased the expression levels of the key genes such as c-Myc and Bcl-2 in CRC cell lines. Moreover, the ADMET properties prediction results shown that ID-11 possess well metabolic characteristics without obvious toxicities. Our data demonstrated that compound ID-11 may be a promising anti-CRC agent and deserved for further development.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013859 Thiocarbamates Carbamates in which the -CO- group has been replaced by a -CS- group. Thiocarbamate
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription

Related Publications

Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
November 2019, Molecules (Basel, Switzerland),
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
May 2020, Chemical & pharmaceutical bulletin,
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
January 2021, Anti-cancer agents in medicinal chemistry,
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
September 2018, Molecules (Basel, Switzerland),
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
January 2016, Anti-cancer agents in medicinal chemistry,
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
January 2015, Bioorganicheskaia khimiia,
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
October 2022, Molecules (Basel, Switzerland),
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
February 2017, Bioorganic & medicinal chemistry letters,
Heping Zhu, and Shilong Ying, and Bingluo Zhou, and Xinyang Hu, and Xiao Liang, and Wangyu Li, and Dungai Wang, and Hongchuan Jin, and Yuanjiang Pan
February 2020, RSC advances,
Copied contents to your clipboard!